title: Oral pentoxifylline vs topical betamethasone in Schamberg disease: a comparative randomized investigator-blinded parallel-group trial.
authors.forename: Saumya
authors.initials: S
authors.lastname: Panda
authors.forename: Subrata
authors.initials: S
authors.lastname: Malakar
authors.forename: Koushik
authors.initials: K
authors.lastname: Lahiri
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage*; D010859:Pigmentation Disorders / Q000175:diagnosis / Q000188:drug therapy*; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D001623:Betamethasone; D010431:Pentoxifylline